Assignee
GENEXINE INC
KR·18 granted patents·11 pending applications·69 citations·filing 2003–2025
Top patents by PatentIndex Score
29 records- 0192US10208099B2Modified interleukin-7 proteinGENEXINE INC·Filed 2016·Granted Feb 19, 2019·18 cites·5 claims
- 0288US10844104B2Modified interleukin-7 proteinGENEXINE INC·Filed 2018·Granted Nov 24, 2020·4 cites·8 claims
- 0387US11041007B2Modified interleukin-7 proteinGENEXINE INC·Filed 2018·Granted Jun 22, 2021·3 cites·12 claims
- 0485US11135262B2Methods of treating cervical cancerGENEXINE INC·Filed 2015·Granted Oct 5, 2021·5 cites·26 claims
- 0585US7989425B2Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirusGENEXINE INC·Filed 2003·Granted Aug 2, 2011·31 cites·21 claims
- 0679US12479898B2Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseasesGENEXINE INC·Filed 2023·Granted Nov 25, 2025·0 cites·18 claims
- 0778US11548927B2Formulation of modified interleukin-7 fusion proteinGENEXINE INC·Filed 2016·Granted Jan 10, 2023·2 cites·13 claims
- 0874US11708399B2Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseasesGENEXINE INC·Filed 2016·Granted Jul 25, 2023·1 cites·16 claims
- 0974US9399665B2Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancerGENEXINE INC·Filed 2015·Granted Jul 26, 2016·2 cites·19 claims
- 1072US12344647B2Formulation of modified interleukin-7 fusion proteinGENEXINE INC·Filed 2022·Granted Jul 1, 2025·0 cites·20 claims
- 1171US12357677B2Virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion proteinGENEXINE INC·Filed 2022·Granted Jul 15, 2025·0 cites·17 claims
- 1270US11357827B2Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion proteinGENEXINE INC·Filed 2016·Granted Jun 14, 2022·1 cites·8 claims
- 1369US10538569B2Fusion polypeptide containing GLP and immunoglobulin hybrid Fc and use thereofGENEXINE INC·Filed 2015·Granted Jan 21, 2020·2 cites·12 claims
- 1466US2025257108A1Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseasesGENEXINE INC·Filed 2025·Application pending·0 cites
- 1564US2025257109A1Formulation of modified interleukin-7 fusion proteinGENEXINE INC·Filed 2025·Application pending·0 cites
- 1660US11883479B2Method for treating cervical cancerGENEXINE INC·Filed 2021·Granted Jan 30, 2024·0 cites·21 claims
- 1759US2022096589A1Methods of treating cervical cancerGENEXINE INC·Filed 2021·Application pending·0 cites
- 1859US2025188182A1Triple combination drug dosing therapy for head and neck cancer treatmentGENEXINE INC·Filed 2023·Application pending·0 cites
- 1955US2025026804A1High-concentration administration formulation of hgh fusion proteinGENEXINE INC·Filed 2022·Application pending·0 cites
- 2055US2021324027A1Modified interleukin-7 proteins and uses thereofGENEXINE INC·Filed 2021·Application pending·0 cites
- 2155US2025025418A1Hyaluronic acid-lipid derivative, lipid nanoparticle comprising same, and use thereofGENEXINE INC·Filed 2022·Application pending·0 cites
- 2253US2023123454A1Fusion protein comprising pd-l1 protein and use thereofGENEXINE INC·Filed 2021·Application pending·0 cites
- 2348US11524054B2Method of treating anemia using long-acting EPO formulationGENEXINE INC·Filed 2016·Granted Dec 13, 2022·0 cites·16 claims
- 2447US11001620B2Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormoneGENEXINE INC·Filed 2016·Granted May 11, 2021·0 cites·13 claims
- 2546US12427186B2Method for treating growth hormone deficiency employing hGH fusion proteinGENEXINE INC·Filed 2017·Granted Sep 30, 2025·0 cites·7 claims
- 2643US2020282021A1Glp-1 fusion proteins and uses thereofGENEXINE INC·Filed 2020·Application pending·0 cites
- 2742US12233113B2Pharmaceutical composition comprising recombinant hGH for the treatment of growth hormone deficiencyGENEXINE INC·Filed 2017·Granted Feb 25, 2025·0 cites·4 claims
- 2833US2016108105A1Human igg4 fc polypeptide variantGENEXINE INC·Filed 2015·Application pending·0 cites
- 2928US2017189476A1Pd-l1 fusion protein and use thereofGENEXINE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENEXINE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →